Triple

T21206815
Position Surface form Disambiguated ID Type / Status
Subject John Stuelpnagel E522606 entity
Predicate boardMemberOf P10 FINISHED
Object Element Biosciences
Element Biosciences is a biotechnology company that develops next-generation DNA sequencing platforms and technologies for genomic research.
 E1472104 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Element Biosciences | Statement: [John Stuelpnagel, boardMemberOf, Element Biosciences]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Element Biosciences
Context triple: [John Stuelpnagel, boardMemberOf, Element Biosciences]
  • A. BD Biosciences
    BD Biosciences is a biotechnology company that develops and supplies research and clinical tools, including cell analysis instruments, reagents, and culture media, for life science and medical laboratories worldwide.
  • B. Corning Life Sciences
    Corning Life Sciences is a division of Corning that develops and manufactures laboratory consumables and equipment used in cell culture, genomics, drug discovery, and other life science research applications.
  • C. Molecular Devices
    Molecular Devices is a life sciences company that develops and manufactures analytical instruments and software for high-throughput screening, cellular imaging, and microplate detection used in biological research and drug discovery.
  • D. New England Biolabs
    New England Biolabs is a biotechnology company renowned for producing molecular biology reagents, particularly restriction enzymes and DNA-modifying tools used in research laboratories worldwide.
  • E. Quanterix
    Quanterix is a biotechnology company specializing in ultra-sensitive digital immunoassay technologies for biomarker detection and precision health diagnostics.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Element Biosciences
Triple: [John Stuelpnagel, boardMemberOf, Element Biosciences]
Generated description
Element Biosciences is a biotechnology company that develops next-generation DNA sequencing platforms and technologies for genomic research.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Element Biosciences
Target entity description: Element Biosciences is a biotechnology company that develops next-generation DNA sequencing platforms and technologies for genomic research.
  • A. BD Biosciences
    BD Biosciences is a biotechnology company that develops and supplies research and clinical tools, including cell analysis instruments, reagents, and culture media, for life science and medical laboratories worldwide.
  • B. Corning Life Sciences
    Corning Life Sciences is a division of Corning that develops and manufactures laboratory consumables and equipment used in cell culture, genomics, drug discovery, and other life science research applications.
  • C. Molecular Devices
    Molecular Devices is a life sciences company that develops and manufactures analytical instruments and software for high-throughput screening, cellular imaging, and microplate detection used in biological research and drug discovery.
  • D. New England Biolabs
    New England Biolabs is a biotechnology company renowned for producing molecular biology reagents, particularly restriction enzymes and DNA-modifying tools used in research laboratories worldwide.
  • E. Quanterix
    Quanterix is a biotechnology company specializing in ultra-sensitive digital immunoassay technologies for biomarker detection and precision health diagnostics.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b5112d8881909510b2dcdc93106d completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e73435322c8190bf4156fbd14edc5c completed April 21, 2026, 8:24 a.m.
NED1 Entity disambiguation (via context triple) batch_6a097ed2c0b48190bcaf2937004abbfd completed May 17, 2026, 8:39 a.m.
NEDg Description generation batch_6a0980329bb4819088da49aec70f27a0 completed May 17, 2026, 8:45 a.m.
NED2 Entity disambiguation (via description) batch_6a0981b76b108190a0c9ae60c81bd4fc completed May 17, 2026, 8:52 a.m.
Created at: April 16, 2026, 3:24 p.m.